Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Scientific Reports
|
February 20, 2021
Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community
Hye Kyung Lee, Ludwig Knabl, Lisa Pipperger, et al.
Applied Optics
|
April 5, 2011
Mixed oxide coatings for optics
Olaf Stenzel, Steffen Wilbrandt, Mark Schürmann, et al.
The Lancet. Neurology
|
December 2, 2014
Thrombolysis and clinical outcome in patients with stroke after implementation of the Tyrol Stroke Pathway: a retrospective observational study
Johann Willeit, Theresa Geley, Johannes Schöch, et al.
The Lancet. Respiratory Medicine
|
June 14, 2021
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
Axel Bauer, Michael Schreinlechner, Nikolay Sappler, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Scientific Reports
|
February 20, 2021
Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community
Hye Kyung Lee, Ludwig Knabl, Lisa Pipperger, et al.
Applied Optics
|
April 5, 2011
Mixed oxide coatings for optics
Olaf Stenzel, Steffen Wilbrandt, Mark Schürmann, et al.
The Lancet. Neurology
|
December 2, 2014
Thrombolysis and clinical outcome in patients with stroke after implementation of the Tyrol Stroke Pathway: a retrospective observational study
Johann Willeit, Theresa Geley, Johannes Schöch, et al.
The Lancet. Respiratory Medicine
|
June 14, 2021
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
Axel Bauer, Michael Schreinlechner, Nikolay Sappler, et al.
Page
of 5